October 22, 2016 8:49 PM ET


Company Overview of Regulus Therapeutics Inc.

Executive Profile

Paul C. Grint M.D.

Chief Executive Officer, President and Director, Regulus Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 11 different industries.

See Board Relationships
As of Fiscal Year 2015


Dr. Paul C. Grint, M.D., has been the Chief Executive Officer and President of Regulus Therapeutics Inc. since June 1, 2015 and served as its Chief Medical Officer from June 16, 2014 to June 1, 2015. Dr. Grint has over two decades of experience in biologics and small molecule development, including the successful commercialization of products in oncology, anti-infectives and immunology. Prior to Regulus, Dr. Grint served as the President at Cerexa, Inc. and was responsible ...

Corporate Headquarters

3545 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-202-6300
Fax: --

Board Members Memberships

Non-Executive Director and Member of Compensation Committee
Chief Executive Officer, President and Director


Bachelor's Degree
Barts & The London School of Medicine & Dentistry, Queen Mary University of London
Saint Bartholomew Medical School, London University

Other Affiliations

Annual Compensation

Total Annual Compensation$446,532

Stocks Options

All Other Compensation$4,022
Exercisable Options$140,416
Unexercisable Options$730,454
Total Number of Options$973,522

Total Compensation

Total Annual Cash Compensation$700,554
Total Short Term Compensation$446,532
Other Long Term Compensation$4,022
Total Calculated Compensation$5,006,729

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Andrew Rackear J.D.Chief Executive Officer and Secretary
Enzon Pharmaceuticals Inc.
Gregory West CAChief Executive Officer and Company Secretary
Benitec Biopharma Limited
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Executive Director
Arbutus Biopharma Corporation
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
Robert W. Overell Ph.D.Co-Founder, Chief Executive Officer, President and Director
PhaseRx, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Regulus Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.